e-learning
resources
ERJ
2008
Login
Search all ERS
e-learning
resources
Disease Areas
Airways Diseases
Interstitial Lung Diseases
Respiratory Critical Care
Respiratory Infections
Paediatric Respiratory Diseases
Pulmonary Vascular Diseases
Sleep and Breathing Disorders
Thoracic Oncology
Events
International Congress
Courses
Webinars
Conferences
Research Seminars
Journal Clubs
Publications
Breathe
Monograph
ERJ
ERJ Open Research
ERR
European Lung White Book
Handbook Series
Guidelines
All ERS guidelines
e-learning
CME Online
Case reports
Short Videos
SpirXpert
Procedure Videos
CME tests
Reference Database of Respiratory Sounds
Radiology Image Challenge
Brief tobacco interventions
EU Projects
VALUE-Dx
ERN-LUNG
ECRAID
UNITE4TB
Disease Areas
Events
Publications
Guidelines
e-learning
EU Projects
Login
Search
Desmosine as a biomarker of elastin degradation in COPD: current status and future directions
Luisetti M., Ma S., Iadarola P., Stone P. J., Viglio S., Casado B., Lin Y. Y., Snider G. L., Turino G. M.
Source:
Eur Respir J 2008; 32: 1146-1157
Journal Issue:
November
Disease area:
Airway diseases
Rating:
You must
login
to grade this presentation.
Share or cite this content
Citations should be made in the following way:
Luisetti M., Ma S., Iadarola P., Stone P. J., Viglio S., Casado B., Lin Y. Y., Snider G. L., Turino G. M.. Desmosine as a biomarker of elastin degradation in COPD: current status and future directions. Eur Respir J 2008; 32: 1146-1157
You must
login
to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
No comment yet.
You must
Login
to comment this presentation.
Related content which might interest you:
Panel discussion on ERS Statement – A core outcome set for clinical trials evaluating the management of COPD exacerbations
ERS statement: a core outcome set for clinical trials evaluating the management of COPD exacerbations
Evidence-based eHealth for COPD
Related content which might interest you:
Quantitative intact proteomics investigations of alveolar macrophages in sarcoidosis
Source: Eur Respir J 2013; 41: 1331-1339
Year: 2013
Changes in bronchoalveolar lavage fluid proteins in sarcoidosis: a proteomics approach
Source: Eur Respir J 2003; 21: 414-420
Year: 2003
Quantitative determination of terbinafine (anti-aspergillar drug ) in human plasma and lung tissue by gas-chromatography and mass spectometry (GC-MS)
Source: Eur Respir J 2002; 20: Suppl. 38, 354s
Year: 2002
LSC - 2018 - Characterization of decellularized COPD lung matrices using mass spectrometry proteomics
Source: International Congress 2018 – COPD: novel pathological mechanisms in the airway epithelium
Year: 2018
Metabolic profiling detects biomarkers of protein degradation in COPD patients
Source: Eur Respir J 2012; 40: 345-355
Year: 2012
Contribution of mass spectrometry (SELDI-TOF-MS) to the analysis of low molecular weight proteins in acute and chronic asthma models
Source: Annual Congress 2008 - Novel mechanisms in the pathogenesis of pulmonary inflammation
Year: 2008
Multicapillary ion mobility spectrometry (MCC-IMS) for early identification of bacteria in vitro
Source: International Congress 2017 – How can microbiology and translational research help physicians?
Year: 2017
Development of mass spectrometry approaches to quantifying lipid mediators in airway disease
Source: Annual Congress 2011 - Role of the biomarkers in airway diseases
Year: 2011
Detection of pregnancy in horses by breath analysis using differential ion mobility spectrometry (DMS)
Source: Annual Congress 2011 - Lung function today and tomorrow I
Year: 2011
Clusters of biomarkers in exhaled breath detected by differential ion mobility spectrometry (DMS)
Source: Annual Congress 2011 - Bronchial hyperresponsiveness and exhaled and sputum biomarkers
Year: 2011
Measurement of urinary total desmosine and isodesmosine using isotope-dilution liquid chromatography-tandem mass spectrometry
Source: Annual Congress 2010 - COPD: diagnosis
Year: 2010
The contribution of quantitative determinations through HPLC (high performance liquid chromatography), of the antituberculosis drugs in serum, in prevention of relapses
Source: Eur Respir J 2004; 24: Suppl. 48, 645s
Year: 2004
Methodological issues of sample collection and analysis of exhaled breath
Source: Eur Respir Monogr 2010; 49: 96-114
Year: 2010
A liquid chromatography MS/MS metabolomics study of COPD patients
Source: International Congress 2015 – Monitoring and phenotyping COPD
Year: 2015
Diagnostic accuracy of SELDI-TOF-MS (surface enhanced laser desabsorbtion ionization time of flight mass spectrometry) method in early diagnosis of lung cancer
Source: Annual Congress 2011 - Innovative diagnostic methods for lung cancer
Year: 2011
The application of mass spectrometry to the analysis and characterization of protein and peptide composition in exhaled breath condensate of pneumo-oncological diseased persons
Source: Annual Congress 2011 - Bronchial hyperresponsiveness and exhaled and sputum biomarkers
Year: 2011
Metabolomic fingerprinting of serum samples based on direct infusion mass spectrometry for lung cancer diagnosis
Source: International Congress 2017 – Clinical research in lung cancer: new valuable results on lung cancer detection, prognostic biomarkers, and tyrosine kinase inhibitors
Year: 2017
Linezolid penetrates in human pleural cavity: A pilot study using ultra-high pressure liquid chromatography in tandem with mass spectrometry (UPLC-MS/MS)
Source: International Congress 2014 – Different interesting issues in respiratory infections: 2
Year: 2014
Differential ion mobility spectrometry (DMS) for use in non invasive diagnostic from exhaled air
Source: Annual Congress 2010 - Exhaled biomarkers: smells like disease
Year: 2010
Comparison of DNA strip assay and high performance liquid chromatography (HPLC) analysis of mycolic acids for identification of mycobacterial isolates to the species level
Source: Annual Congress 2008 - Genetics, immunology and microbiology of tuberculosis
Year: 2008
We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking "Accept", you consent to the use of the cookies.
Accept